Clinical Trials Directory

Trials / Completed

CompletedNCT00044798

Magnetic Stimulation Therapy for Treating Vascular Depression

Vascular Depression and Magnetic Stimulation Therapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
132 (estimated)
Sponsor
University of Iowa · Academic / Other
Sex
All
Age
51 Years – 89 Years
Healthy volunteers
Not accepted

Summary

This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).

Detailed description

Vascular depression is a condition that typically affects the elderly and is associated with small vascular lesions. It is more resistant to treatment and has a poorer outcome than nonvascular depression. By altering excitability in the cortical area of the brain, rTMS may be an effective treatment neuropsychiatric conditions, particularly depression. Participants in this study will be randomly assigned to 15 treatments of either rTMS or sham rTMS for 3 weeks. Following treatment, participants will receive citalopram for 9 weeks. Response rates to treatment; relapse rates; the size, number, and location of the vascular lesions; and the amount of regional brain atrophy will be measured. Improvements in activities of daily living, quality of life, and cognitive function will also be also measured.

Conditions

Interventions

TypeNameDescription
PROCEDURERepetitive transcranial magnetic stimulation (rTMS)Participants will receive 15 treatments of rTMS over 3 weeks.
DRUGCitalopramAfter completing treatment with rTMS or sham rTMS, participants will take citalopram for 9 weeks.
PROCEDURESham rTMSParticipants will receive 15 treatments of sham rTMS over 3 weeks.

Timeline

Start date
2001-09-01
Primary completion
2007-03-01
Completion
2008-08-01
First posted
2002-09-06
Last updated
2013-09-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00044798. Inclusion in this directory is not an endorsement.